Skip to content
TrackPodcasts
businessMar 27, 20262:00

Steep Losses Send Dow Into Correction Territory

Minute Briefing

About this episode

Dow slides 1.7%, as the S&P 500 posts its fifth straight week of losses. Plus: Carnival shares drop after the cruise line cuts its outlook. And AstraZeneca shares rise after successful clinical trial results. Katherine Sullivan hosts. Sign up for the WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Get every episode summarized

Each time Minute Briefing publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

Transcript ready

26 searchable segments. Every word is indexed and playable.

Steep Losses Send Dow Into Correction Territory

Minute Briefing

0:00
2:00

Full transcript

Minute BriefingSteep Losses Send Dow Into Correction Territory. Machine-transcribed; use the interactive transcript above to jump the player to any line.

Here's your closing bell brief for Friday, March 27. I'm Katherine Sullivan for the Wall Street Journal. US stocks fell sharply again today as geopolitical tensions in the Middle East intensified. The NASDAQ lost more than 2%, the Dow dropped 1.7% to enter correction territory, or more than 10% off its high in February. In the S&P 500, also dropped 1.7% today to close out its fifth straight week of losses. Investors reacted to news of a potentially longer military confrontation between the United States and Iran. Crude oil prices climbed 4% as the conflict continued to threaten energy infrastructure. Gold prices rose 2.7% while the dollar edged higher. Among individual companies, Luminum shares rose 2%, the laser maker plans to build a new manufacturing plant for artificial intelligence data center components. Shares of AstraZeneca gained more than 2.5% in London trading, a new lung disease drug met

its primary goals in two late-stage clinical trials. Carnival shares dropped 4%, after the cruise line cut its full-year profit outlook, management blamed rising fuel costs driven by higher oil prices. Meanwhile, shares of Norwegian cruise line fell nearly 7%, the company announced it would reshape its board following a truce with an activist investor. And shares in the maker of Jack Daniels Whiskey, Brown Foreman, climbed nearly 6% on the news of a potential merger with the French drinks company Pernot Ricard. Its France-listed shares rose 8%. Heads up, an artificial intelligence tool helped us make this episode by creating summaries that were based on WSJ reporting and then reviewed and adapted by an editor. We'll have a lot more coverage of the day's news on the WSJ's What's News podcast. You can add it to your playlist on your smart speaker or listen and subscribe wherever you get your podcasts.

More episodes

More from Minute Briefing

View all episodes →